These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22763645)

  • 1. Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures.
    Velstra B; van der Burgt YE; Mertens BJ; Mesker WE; Deelder AM; Tollenaar RA
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):1983-92. PubMed ID: 22763645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
    Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
    J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
    Schaub NP; Jones KJ; Nyalwidhe JO; Cazares LH; Karbassi ID; Semmes OJ; Feliberti EC; Perry RR; Drake RR
    J Am Coll Surg; 2009 May; 208(5):970-8; discussion 978-80. PubMed ID: 19476873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.
    Velstra B; Vonk MA; Bonsing BA; Mertens BJ; Nicolardi S; Huijbers A; Vasen H; Deelder AM; Mesker WE; van der Burgt YE; Tollenaar RA
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):531-41. PubMed ID: 25240825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-controlled identification of colorectal cancer based on proteomic profiles and the potential for screening.
    Huijbers A; Mesker WE; Mertens BJ; Bladergroen MR; Deelder AM; van der Burgt YE; Tollenaar RA
    Colorectal Dis; 2014 Nov; 16(11):907-13. PubMed ID: 25243779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
    Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
    J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of pancreatic cancer using serum protein profiling.
    Velstra B; Bonsing BA; Mertens BJ; van der Burgt YE; Huijbers A; Vasen H; Mesker WE; Deelder AM; Tollenaar RA
    HPB (Oxford); 2013 Aug; 15(8):602-10. PubMed ID: 23458426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the raw serum peptidomic pattern in glioma patients.
    Li Z; Lu H; Yang J; Zeng X; Zhao L; Li H; Liao Q; Peng S; Zhou M; Wu M; Xiang J; Wang Y; Li G
    Clin Chim Acta; 2013 Oct; 425():221-6. PubMed ID: 23954773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
    Gast MC; Van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
    Oncol Rep; 2009 Jul; 22(1):205-13. PubMed ID: 19513525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum biomarker profiling by solid-phase extraction with particle-embedded micro tips and matrix-assisted laser desorption/ionization mass spectrometry.
    Navare A; Zhou M; McDonald J; Noriega FG; Sullards MC; Fernandez FM
    Rapid Commun Mass Spectrom; 2008 Apr; 22(7):997-1008. PubMed ID: 18320548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALDI-TOF serum protein profiling for the detection of breast cancer.
    de Noo ME; Deelder A; van der Werff M; Ozalp A; Mertens B; Tollenaar R
    Onkologie; 2006 Nov; 29(11):501-6. PubMed ID: 17068384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.
    Tiss A; Timms JF; Smith C; Devetyarov D; Gentry-Maharaj A; Camuzeaux S; Burford B; Nouretdinov I; Ford J; Luo Z; Jacobs I; Menon U; Gammerman A; Cramer R
    Int J Gynecol Cancer; 2010 Dec; 20(9):1518-24. PubMed ID: 21370595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
    Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
    Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
    Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
    Engwegen JY; Helgason HH; Cats A; Harris N; Bonfrer JM; Schellens JH; Beijnen JH
    World J Gastroenterol; 2006 Mar; 12(10):1536-44. PubMed ID: 16570345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
    Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
    Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of inter-day and inter-individual variability of tear peptide/protein profiles by MALDI-TOF MS analyses.
    González N; Iloro I; Durán JA; Elortza F; Suárez T
    Mol Vis; 2012; 18():1572-82. PubMed ID: 22736947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a 17-protein signature in the serum of lung cancer patients.
    Sreseli RT; Binder H; Kuhn M; Digel W; Veelken H; Sienel W; Passlick B; Schumacher M; Martens UM; Zimmermann S
    Oncol Rep; 2010 Jul; 24(1):263-70. PubMed ID: 20514471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing of MALDI-ToF-based low-molecular-weight serum proteome pattern analysis in detection of breast cancer patients; the effect of albumin removal on classification performance.
    Pietrowska M; Marczak L; Polanska J; Nowicka E; Behrent K; Tarnawski R; Stobiecki M; Polanski A; Widlak P
    Neoplasma; 2010; 57(6):537-44. PubMed ID: 20845992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.